Submitted by Anonymous (not verified) on 4 October 2023 - 15:58
Human medicines European public assessment report (EPAR): Colobreathe, colistimethate sodium, Cystic Fibrosis, Date of authorisation: 13/02/2012, Revision: 16, Status: Authorised
Source: